On this episode of Stock Movers:
- Novo Nordisk’s new Wegovy obesity pill fueled sales in the first quarter and the drugmaker said this year’s declines won’t be as bad as expected, a relief for investors.
- BMW’s carmaking returns fell in the first quarter as intense competition in China weighed on prices and deliveries in the world’s biggest auto market.
- Diageo’s sales unexpectedly rose in the latest quarter as growth in Africa and Latin America was enough to offset significant weakness in the US.

Novo Nordisk's Pill, BMW's Struggle, Diageo Up
04:51

Super Micro Jumps, AMD Rallies on Upbeat Forecast, Intel Rises
03:13

Financial Service-Related Stocks Slip, PayPal Falls, Coinbase Drops
04:03